On Thursday, Guggenheim, a global investment and advisory firm, downgraded pharmaceutical giant GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK (LON:GSK)) stock from Buy to Neutral. The change in rating ...

Asian shares struggled for direction after Wall Street edged lower, with traders bracing for the Federal Reserve’s final policy decision of the year. Equities slipped in Japan in early trade while ...